Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Olchanski

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 12, 2017
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction ModelsNatalia Olchanski, Joshua T Cohen, Peter J Neumann, et al.
Acta Diabetologica|January 31, 2021
Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrainedNatalia Olchanski, David van Klaveren, Joshua T Cohen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 29, 2025
Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation StudyYingying Zhu, Natalia Olchanski, Karen M Freund, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2022
The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case StudiesSiyu Ma, Natalia Olchanski, Joshua T Cohen, et al.
Clinical Therapeutics|March 16, 2013
The economic burden of treatment-resistant depressionNatalia Olchanski, Michelle McInnis Myers, Marilyn Halseth, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 4, 2011
Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failurePhilip L Cyr, Katherine A Slawsky, Natalia Olchanski, et al.
The Lancet. Infectious Diseases|May 28, 2005
A synthesis of cost-utility analysis literature in infectious diseasePatricia W Stone, Bruce R Schackman, Christopher P Neukermans, et al.
Journal of Medical Systems|September 19, 2017
Can a Novel ICU Data Display Positively Affect Patient Outcomes and Save Lives?Natalia Olchanski, Mikhail A Dziadzko, Ing C Tiong, et al.
Journal of the American Geriatrics Society|March 20, 2024
Racial and ethnic differences in disease course Medicare expenditures for beneficiaries with dementiaNatalia Olchanski, Yingying Zhu, Lichen Liang, et al.
Journal of Alzheimer'S Disease : JAD|November 13, 2023
Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of LifeYingying Zhu, Natalia Olchanski, Joshua T Cohen, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 12, 2017
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction ModelsNatalia Olchanski, Joshua T Cohen, Peter J Neumann, et al.
Acta Diabetologica|January 31, 2021
Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrainedNatalia Olchanski, David van Klaveren, Joshua T Cohen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 29, 2025
Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation StudyYingying Zhu, Natalia Olchanski, Karen M Freund, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2022
The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case StudiesSiyu Ma, Natalia Olchanski, Joshua T Cohen, et al.
Clinical Therapeutics|March 16, 2013
The economic burden of treatment-resistant depressionNatalia Olchanski, Michelle McInnis Myers, Marilyn Halseth, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 4, 2011
Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failurePhilip L Cyr, Katherine A Slawsky, Natalia Olchanski, et al.
The Lancet. Infectious Diseases|May 28, 2005
A synthesis of cost-utility analysis literature in infectious diseasePatricia W Stone, Bruce R Schackman, Christopher P Neukermans, et al.
Journal of Medical Systems|September 19, 2017
Can a Novel ICU Data Display Positively Affect Patient Outcomes and Save Lives?Natalia Olchanski, Mikhail A Dziadzko, Ing C Tiong, et al.
Journal of the American Geriatrics Society|March 20, 2024
Racial and ethnic differences in disease course Medicare expenditures for beneficiaries with dementiaNatalia Olchanski, Yingying Zhu, Lichen Liang, et al.
Journal of Alzheimer'S Disease : JAD|November 13, 2023
Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of LifeYingying Zhu, Natalia Olchanski, Joshua T Cohen, et al.
Pageof 3